0 results

Patient Corner

Anatomical Illustrations

More

Last reference updates

  • Mar 1, 2017 - FDA Drug Updates

Approval of Xermelo (telotristat ethyl) for carcinoid syndrome diarrhea

FDA approved Xermelo (telotristat ethyl) for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog

Read more
  • Feb 28, 2017 - MedWatch Drug Updates

Recall of Edex (alprostadil injection) 10 mcg by Endo Pharmaceuticals - Lack of sterility assurance

Endo Pharmaceuticals recalled the Edex (alprostadil injection) 10 mcg due to the potential lack of sterility assurance

Read more
  • Feb 27, 2017 - MedWatch Drug Updates

Recall of unexpired sterile injectable labelled “Latex Free” by Advanced Pharma as it may contain synthetic/natural latex

Advanced Pharma issued voluntary recall of unexpired sterile injectable labeled “latex free” due to the presence of synthetic/natural latex

Read more
  • Feb 23, 2017 - MedWatch Drug Updates

Recall of XtraHRD Natural Male Enhancement Capsules by Organic Herbal Supply - Contains undeclared drug ingredients

Recall of XtraHRD Natural Male Enhancement by Organic Herbal Supply as it was found to contain undeclared tadalafil

Read more
  • Feb 16, 2017 - MedWatch Drug Updates

Recall of Human chorionic gonadotropin freeze dried vials by Synergy Rx – Lack of sterility assurance

Synergy Rx Pharmacy recalled the Human chorionic gonadotropin (HCG) 5,000 and 11,000 units/vial due to a lack of sterility assurance

Read more
  • Feb 16, 2017 - FDA Drug Updates

FDA approves Siliq (brodalumab) for psoriasis

Siliq (brodalumab) is indicated in patients who are candidates for systemic therapy or phototherapy

Read more
  • Feb 15, 2017 - FDA Drug Updates

FDA approved Parsabiv (etelcalcetide) for hyperparathyroidism in dialysis patients

Parsabiv (etelcalcetide) can be administered intravenously at the end of the hemodialysis session

Read more
  • Feb 10, 2017 - FDA Drug Updates

FDA approval of Emflaza (deflazacort) for duchenne muscular dystrophy

FDA approved Emflaza (deflazacort) for duchenne muscular dystrophy in >=5 years old patients

Read more
  • Feb 10, 2017 - MedWatch Drug Updates

Recall of Well Balance Xanthium & Siler Combo dietary supplement by Kingsway - Contains banned ephedra alkaloids

Kingsway Trading has initiated the recall of Well Balance Xanthium & Siler Combo dietary supplement due to the presence of undeclared ephedra alkaloids

Read more
  • Feb 10, 2017 - MedWatch Drug Updates

Class I Recall of Alaris Syringe Pump Module by CareFusion – Faulty sensor may generate false alarm

CareFusion is recalling the Alaris Syringe Pump because of faulty Air-In-Line (AIL) sensor which may generate a false alarm

Read more